Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC vs D-TACE with Lenvatinib and Tislelizumab in Advanced HCC
NCT05582278Phase 2Unknown
- Start
- Jan 2021
- Primary completion
- Jan 2024
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05582278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05582278.